LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...
Why scream into the void when you can talk to the machine? These days, tech-obsessed folks are turning to artificial ...
In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy ...
A groundbreaking study from Brown University shows that AI chatbots like ChatGPT, when used for mental health advice, can ...
Currently there is no vaccine to prevent this virus and no specific antiviral therapy to treat HMPV, according to the CDC.
Longitudinal PRO modeling, rather than time-to-worsening censoring, indicated maintained HRQOL and pain outcomes with ...
A promising combination for multiple myeloma received FDA approval as a second-line therapy. The approval of teclistamab (Tecvayli) plus daratumumab hyaluronidase (Darzalex Faspro) stipulates use in ...
The agency pointed to what it sees as a contradictory signal within uniQure's own dataset. Sham-controlled data from a small cohort of U.S. patients showed no treatment effect at 12 months, a finding ...
Immunotherapy has transformed the way physicians treat patients. In the context of cancer, immune cells are suppressed and ...
Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...
U.S. Physical Therapy (NYSE:USPH) highlighted improved profitability and record patient volumes in its fourth-quarter and ...
A trainer shares 5 bed exercises for back pain after 60 that rebuild strength and stability — no equipment or floor work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results